CoChat

2011 updateJapaneseSociety forDialysisTherapy Guidelines of Vascular Access Construction and Repair for Chronic Hemodialysis

Open access
Kukita, Kazutaka, Ohira, Seiji, Amano, Izumi, Naito, Hidemune, Azuma, Nakanobu, Ikeda, Kiyoshi, Kanno, Yutaka, Satou, Takashi, Sakai, Shinji, Sugimoto, Tokuichiro, Takemoto, Yoshiaki, Haruguchi, Hiroaki, Minakuchi, Jun, Miyata, Akira, Murotani, Noriyoshi, Hirakata, Hideki, Tomo, Tadashi, Akizawa, Tadao, Vascular Access Construction and Repair for Chronic Hemodialysis Guideline Working Group, Japanese Society for Dialysis Therapy · 2015 · Therapeutic Apheresis and Dialysis
Cited by 211

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

The first edition of the Guidelines for the Construction and Repair of Vascular Access in Chronic Hemodialysis was published by the Japan Society for Dialysis Therapy (JSDT) in 2005, under Seiji Ohira, Chairman. Recently, many presentations making reference to the guidelines have appeared in conferences and journals. The 2011 version uses this first edition as a foundation and was formed with a collection of data following the publication of the first edition. During this time, in 2008, the JSDT conducted a survey on the conditions of vascular access (VA), where it found that native arteriovenous fistula (AVF) made up 89.7%, synthetic arteriovenous grafts (AVGs) were 7.1%, superficialization 1.8%, other direct arterial puncture 0.1%, long-term indwelled catheters 0.5%, temporary venous catheters 0.5%, single-needle dialysis 0.2%, and other methods 0.1% 1. In a survey conducted 10 years earlier, in 1998, AVF usage was at 91.4%, AVGs were 4.8%, superficialization was 2.5%, external shunts 0.2%, and other methods 1.1% 2 (Table 1). In other words, with an increase in long-term dialysis cases and damage to native vessels due to advanced age, internal shunts with native vessels are on the decrease; this implies that the use of AVG will increase. In the 2008 survey, other methods made up 0.1%: catheters were not categorized within this survey but may have been included. In these guidelines, in addition to the level of evidence, the level of recommendation has been included, and the categories are evaluated with both. As the Kidney Disease: Improving Global Outcomes (KDIGO) 3 uses the Grading of Recommendations Assessment, Development and Evaluation (GRADE) as a method of evaluating evidence, the Evidence Level Evaluation Committee of the JSDT made considerations 4 and based their method on that. With regard to study design, random controlled trials (RCT) were rated as high, observational studies as low, and all others as very low. Considerations for contents, quality, bias, etc. were given a two-level plus or minus point; in the end, they were divided into four levels, "A–D" (Table 2). "A" may represent high, "C" low, and "D" very low, and plus and minus points assigned accordingly. Where evidence is not shown, the committee has assigned an expert opinion (O). Because the number of RCTs in kidney-related fields is extremely limited, the evidence level was expected to be low, and there was a possibility that most proposals would be weak. Levels of recommendation have been divided into Level 1: Strong and Level 2: Weak, but if an "expert judgment" has shown them to be clinically important, even though the evidence level may be weak, they were strongly recommended. The opposite is also true. In this manner, the level of recommendation is denoted together with the evidence level. As an example, where the evidence level is "low" but the level of recommendation is "strong," would be written as "1C." In the case where the evidence level is "medium" and the level of recommendation is "weak," would be written as "2B" (Table 2). "Expert judgment" was decided in various meetings as listed. Purpose of VA construction VA construction method (surgical method) and presurgery examinations Anesthesia Time required for surgery What to be careful of following surgery Actual usage (actual cannulation) VA surgeon Patency rates for various Vas Importance of periodic examinations of function and shape Anticipated VA complications Repair methods for VA complications Others Inadequate blood flow Stenosis (arterial/venal stricture) Thrombosis (VA obstruction) Infection of cannulation sites Aneurysms Vascular hypertension (sore thumb or sore hand syndrome) Steal syndrome (ischemia) Excess blood flow, high-output cardiac failure Recirculation Cannulation difficulty, limited cannulation area Others 1. 2. The attending physician has the duty to explain to end-stage renal disease (ESRD) patients about the treatment methods deemed necessary for them 5, 6. 3. Topics that the explanation should cover are listed in Table 1; however, it is best to discuss these based upon the stage of disease, condition, and degree of understanding of the patient. Information should not be limited to what the medical side thinks is necessary; information the patient desires or what we imagine they would want should be included as part of the explanation. It is best not to explain everything at one time but to repeat the explanation in a series of meetings 7, 8. 4. The dialysis physician should provide a broad general explanation, but it falls upon the access surgeon to provide a detailed explanation of the actual VA construction. 5. When the method of VA has been decided upon, a detailed explanation of the necessity and characteristics should be provided, especially in the case of grafts 9. 6. The explanation of VA should include discussion of the various complications that could develop. 1. Taking into consideration the availability of the simple eGFR conversion eq

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/1744-9987.12296

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Metadata

Authors
Kukita, K., Ohira, S., Amano, I., Naito, H., Azuma, N., Ikeda, K., Kanno, Y., Satou, T., Sakai, S., Sugimoto, T., Takemoto, Y., Haruguchi, H., Minakuchi, J., Miyata, A., Murotani, N., Hirakata, H., Tomo, T., Akizawa, T., & Vascular Access Construction and Repair for Chronic Hemodialysis Guideline Working Group, J. S. F. D. T.
Venue
Therapeutic Apheresis and Dialysis
Publisher
Wiley
Published
2015-03
Volume
19
Issue
S1
Pages
1-39
ISSN
  • 1091-6660 (ISSN-L)
  • 1744-9979
  • 1744-9987
OpenAlex
W4294571461
Cited by
211
References
2
FWCI
21.28
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.